Uptake of depreotide in a patient with lung cancer and bone metastases.
Gao
Zairong
Z
Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Biersack
Hans-Jürgen
HJ
Bucerius
Jan
J
D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism* / Q000556:secondary; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism*; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D003074:Solitary Pulmonary Nodule / Q000000981:diagnostic imaging* / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D014915:Whole-Body Counting / Q000379:methods
D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D013004:Somatostatin; C024226:technetium Tc 99m hydroxymethylene diphosphonate; C444119:technetium Tc 99m depreotide; D013669:Technetium Tc 99m Medronate